U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

1993
138
Substance Class Protein
Created
by admin
on Wed Apr 02 09:40:35 GMT 2025
Edited
by admin
on Wed Apr 02 09:40:35 GMT 2025
Protein Type FAB
Protein Sub Type IGG1
Sequence Origin HUMANIZED MOUSE
Sequence Type COMPLETE
Record UNII
X85G7936GV
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
ABCIXIMAB
INN   MART.   MI   USAN   VANDF   WHO-DD  
INN   USAN  
Official Name English
ABCIXIMAB (GENETICAL RECOMBINATION)
JAN  
Preferred Name English
ABCIXIMAB [MI]
Common Name English
Abciximab [WHO-DD]
Common Name English
ABCIXIMAB (GENETICAL RECOMBINATION) [JAN]
Common Name English
C7E3
Code English
ABCIXIMAB [JAN]
Common Name English
abciximab [INN]
Common Name English
ABCIXIMAB [MART.]
Common Name English
MABFRAG CHIMERIC (IGG1) ANTI P08514 (ITA2B_HUMAN) (IBD657)
Common Name English
ABCIXIMAB [PURPLE BOOK CDER]
Common Name English
ABCIXIMAB [VANDF]
Common Name English
ABCIXIMAB [USAN]
Common Name English
REOPRO
Brand Name English
Immunoglobulin G1, anti-(human integrin ?IIb?3) Fab fragment (human-mouse monoclonal c7E3 clone p7E3VHhC?1 ?1-chain), disulfide with human-mouse monoclonal c7E3 clone p7E3V?hC? ?-chain
Common Name English
Classification Tree Code System Code
WHO-ATC B01AC13
Created by admin on Wed Apr 02 09:40:35 GMT 2025 , Edited by admin on Wed Apr 02 09:40:35 GMT 2025
WHO-VATC QB01AC13
Created by admin on Wed Apr 02 09:40:35 GMT 2025 , Edited by admin on Wed Apr 02 09:40:35 GMT 2025
NCI_THESAURUS C20401
Created by admin on Wed Apr 02 09:40:35 GMT 2025 , Edited by admin on Wed Apr 02 09:40:35 GMT 2025
Code System Code Type Description
LACTMED
Abciximab
Created by admin on Wed Apr 02 09:40:35 GMT 2025 , Edited by admin on Wed Apr 02 09:40:35 GMT 2025
PRIMARY
MESH
C085843
Created by admin on Wed Apr 02 09:40:35 GMT 2025 , Edited by admin on Wed Apr 02 09:40:35 GMT 2025
PRIMARY
ChEMBL
CHEMBL1201584
Created by admin on Wed Apr 02 09:40:35 GMT 2025 , Edited by admin on Wed Apr 02 09:40:35 GMT 2025
PRIMARY
DRUG CENTRAL
4950
Created by admin on Wed Apr 02 09:40:35 GMT 2025 , Edited by admin on Wed Apr 02 09:40:35 GMT 2025
PRIMARY
USAN
FF-7
Created by admin on Wed Apr 02 09:40:35 GMT 2025 , Edited by admin on Wed Apr 02 09:40:35 GMT 2025
PRIMARY
IUPHAR
6584
Created by admin on Wed Apr 02 09:40:35 GMT 2025 , Edited by admin on Wed Apr 02 09:40:35 GMT 2025
PRIMARY
EVMPD
SUB00233MIG
Created by admin on Wed Apr 02 09:40:35 GMT 2025 , Edited by admin on Wed Apr 02 09:40:35 GMT 2025
PRIMARY
FDA UNII
X85G7936GV
Created by admin on Wed Apr 02 09:40:35 GMT 2025 , Edited by admin on Wed Apr 02 09:40:35 GMT 2025
PRIMARY
WIKIPEDIA
ABCIXIMAB
Created by admin on Wed Apr 02 09:40:35 GMT 2025 , Edited by admin on Wed Apr 02 09:40:35 GMT 2025
PRIMARY
NCI_THESAURUS
C76128
Created by admin on Wed Apr 02 09:40:35 GMT 2025 , Edited by admin on Wed Apr 02 09:40:35 GMT 2025
PRIMARY
SMS_ID
100000078823
Created by admin on Wed Apr 02 09:40:35 GMT 2025 , Edited by admin on Wed Apr 02 09:40:35 GMT 2025
PRIMARY
RXCUI
83929
Created by admin on Wed Apr 02 09:40:35 GMT 2025 , Edited by admin on Wed Apr 02 09:40:35 GMT 2025
PRIMARY RxNorm
INN
7200
Created by admin on Wed Apr 02 09:40:35 GMT 2025 , Edited by admin on Wed Apr 02 09:40:35 GMT 2025
PRIMARY
MERCK INDEX
m1275
Created by admin on Wed Apr 02 09:40:35 GMT 2025 , Edited by admin on Wed Apr 02 09:40:35 GMT 2025
PRIMARY Merck Index
HSDB
8179
Created by admin on Wed Apr 02 09:40:35 GMT 2025 , Edited by admin on Wed Apr 02 09:40:35 GMT 2025
PRIMARY
CAS
143653-53-6
Created by admin on Wed Apr 02 09:40:35 GMT 2025 , Edited by admin on Wed Apr 02 09:40:35 GMT 2025
PRIMARY
DRUG BANK
DB00054
Created by admin on Wed Apr 02 09:40:35 GMT 2025 , Edited by admin on Wed Apr 02 09:40:35 GMT 2025
PRIMARY
From To
2_134 2_194
2_23 2_88
1_221 2_214
1_145 1_201
1_22 1_96
Related Record Type Details
HIGH AFFINITY IMMUNOGLOBULIN GAMMA FC RECEPTOR I
TARGET -> AGONIST
INTEGRIN ALPHA-IIB
TARGET -> INHIBITOR
LOW AFFINITY IMMUNOGLOBULIN .GAMMA. FC REGION RECEPTOR II-A
TARGET -> AGONIST
INTEGRIN BETA-3
TARGET -> INHIBITOR
Related Record Type Details
ABCIXIMAB
ACTIVE MOIETY
Name Property Type Amount Referenced Substance Defining Parameters References
Molecular Formula CHEMICAL
Volume of Distribution PHARMACOKINETIC
MOL_WEIGHT:NUMBER(CALCULATED) CHEMICAL
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966